HealthEquity Inc (HQY)

Inventory turnover

		Jan 31, 2025	Oct 31, 2024	Jul 31, 2024	Apr 30, 2024	Jan 31, 2024	Oct 31, 2023	Jul 31, 2023	Apr 30, 2023	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jul 31, 2021	Apr 30, 2021	Jan 31, 2021	Oct 31, 2020	Jul 31, 2020	Apr 30, 2020
Cost of revenue (ttm)	US$ in thousands	843,849	726,605	670,138	653,576	633,137	716,307	716,519	714,783	713,683	745,181	719,389	706,905	685,117	637,099	630,456	609,252	599,601	521,403	537,391	454,855
Inventory	US$ in thousands	—	—	—	—	—	—	0	0	0	—	—	0	—	—	—	—	—	—	—	—
Inventory turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

January 31, 2025 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $843,849K ÷ $—K
= —

Based on the provided data, HealthEquity Inc does not have specific information available for its inventory turnover ratio for the periods listed from April 2020 to January 2025. The absence of data for this key financial ratio makes it challenging to assess how efficiently the company is managing its inventory levels and replenishments during these periods.

Inventory turnover ratio is a critical metric that indicates how many times a company's inventory is sold and replaced over a given period, reflecting the efficiency of inventory management. A high inventory turnover generally signifies effective inventory management, while a low turnover may indicate overstocking, slow-moving inventory, or potential obsolescence issues.

Without the specific data points for inventory turnover, it becomes difficult to assess the company's inventory management performance or compare it to industry benchmarks. It is essential for HealthEquity Inc to disclose this information in its financial statements to provide investors and analysts with a more comprehensive understanding of its operational efficiency and financial health.